Cipla plans to deliver solutions and therapies unique to customer needs with a special focus on offering solutions for weight management and addressing the issue of obesity.
Cipla (Source: unsplash)
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO, Umang Vohra has said.
The Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25.
"Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche indications...obesity is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra stated.
By continuing you agree to our Privacy Policy & Terms & Conditions